Literature DB >> 21997692

Succinate dehydrogenase-deficient GISTs: a clinicopathologic, immunohistochemical, and molecular genetic study of 66 gastric GISTs with predilection to young age.

Markku Miettinen1, Zeng-Feng Wang, Maarit Sarlomo-Rikala, Czeslaw Osuch, Piotr Rutkowski, Jerzy Lasota.   

Abstract

Most gastrointestinal stromal tumors (GISTs) are driven by KIT or PDGFRA-activating mutations, but a small subset is associated with loss of function of the succinate dehydrogenase (SDH) complex of mitochondrial inner membrane proteins. This occurs by germline mutations of the SDH subunit genes and hitherto unknown mechanisms. SDH-deficient GISTs especially include pediatric GISTs and those associated with Carney triad (CT) or Carney-Stratakis syndromes (CSSs); the latter 2 also include paraganglioma as a component. SDH-deficient GISTs were identified in this study on the basis of immunohistochemical loss of succinate dehydrogenase subunit B (SDHB), which signals functional loss of the SDH complex. We found 66 SDH-deficient GISTs among 756 gastric GISTs, with an estimated frequency of 7.5% of unselected cases. Nearly, all gastric GISTs in patients <20 years, and a substantial percentage of those in patients <40 years, but only rare GISTs in older adults were SDH deficient. There was a female predominance of over 2:1. Two patients each had either pulmonary chondroma or paraganglioma (CT), but none of the examined cases had SDH germline mutations (CSS) or somatic KIT/PDGFRA or BRAF mutations. SDH-deficient GISTs were often multiple and typically showed plexiform muscularis propria involvement and epithelioid hypercellular morphology. They were consistently KIT-positive and DOG1/Ano 1-positive and almost always smooth muscle actin negative. Tumor size and mitotic activity varied, and the tumors were somewhat unpredictable with low mitotic rates developing metastases. Gastric recurrences occurred in 11 patients, and peritoneal and liver metastases occurred in 8 and 10 patients, respectively. Lymph node metastases were detected in 5 patients, but lymphovascular invasion was present in >50% of cases studied; these 2 were not related to adverse outcome. Seven patients died of disease, but many had long survivals, even with peritoneal or liver metastases. All 378 nongastric GISTs and 34 gastric non-GIST mesenchymal tumors were SDHB positive. SDH-deficient GISTs constitute a small subgroup of gastric GISTs; they usually occur in children and young adults, often have a chronic course similar to that of pediatric and CT GISTs, and have potential association with paraganglioma, necessitating long-term follow-up.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21997692      PMCID: PMC3193596          DOI: 10.1097/PAS.0b013e3182260752

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  38 in total

1.  Defects in succinate dehydrogenase in gastrointestinal stromal tumors lacking KIT and PDGFRA mutations.

Authors:  Katherine A Janeway; Su Young Kim; Maya Lodish; Vânia Nosé; Pierre Rustin; José Gaal; Patricia L M Dahia; Bernadette Liegl; Evan R Ball; Margarita Raygada; Angela H Lai; Lorna Kelly; Jason L Hornick; Maureen O'Sullivan; Ronald R de Krijger; Winand N M Dinjens; George D Demetri; Cristina R Antonescu; Jonathan A Fletcher; Lee Helman; Constantine A Stratakis
Journal:  Proc Natl Acad Sci U S A       Date:  2010-12-20       Impact factor: 11.205

2.  Immunohistochemistry for SDHB triages genetic testing of SDHB, SDHC, and SDHD in paraganglioma-pheochromocytoma syndromes.

Authors:  Anthony J Gill; Diana E Benn; Angela Chou; Adele Clarkson; Anita Muljono; Goswin Y Meyer-Rochow; Anne Louise Richardson; Stan B Sidhu; Bruce G Robinson; Roderick J Clifton-Bligh
Journal:  Hum Pathol       Date:  2010-03-17       Impact factor: 3.466

3.  SDHA loss-of-function mutations in KIT-PDGFRA wild-type gastrointestinal stromal tumors identified by massively parallel sequencing.

Authors:  Maria A Pantaleo; Annalisa Astolfi; Valentina Indio; Richard Moore; Nina Thiessen; Michael C Heinrich; Chiara Gnocchi; Donatella Santini; Fausto Catena; Serena Formica; Pier Luigi Martelli; Rita Casadio; Andrea Pession; Guido Biasco
Journal:  J Natl Cancer Inst       Date:  2011-04-19       Impact factor: 13.506

4.  Gastrointestinal glomus tumors: a clinicopathologic, immunohistochemical, and molecular genetic study of 32 cases.

Authors:  Markku Miettinen; Edina Paal; Jerzy Lasota; Leslie H Sobin
Journal:  Am J Surg Pathol       Date:  2002-03       Impact factor: 6.394

5.  Immunohistochemistry for SDHB divides gastrointestinal stromal tumors (GISTs) into 2 distinct types.

Authors:  Anthony J Gill; Angela Chou; Ricardo Vilain; Adele Clarkson; Millie Lui; Richard Jin; Vivienne Tobias; Jaswinder Samra; David Goldstein; Celia Smith; Loretta Sioson; Nicole Parker; Ross C Smith; Mark Sywak; Stan B Sidhu; Jenny Ma Wyatt; Bruce G Robinson; Robert P Eckstein; Diana E Benn; Roderick J Clifton-Bligh
Journal:  Am J Surg Pathol       Date:  2010-05       Impact factor: 6.394

6.  Early-onset renal cell carcinoma as a novel extraparaganglial component of SDHB-associated heritable paraganglioma.

Authors:  Sakari Vanharanta; Mary Buchta; Sarah R McWhinney; Sanna K Virta; Mariola Peçzkowska; Carl D Morrison; Rainer Lehtonen; Andrzej Januszewicz; Heikki Järvinen; Matti Juhola; Jukka-Pekka Mecklin; Eero Pukkala; Riitta Herva; Maija Kiuru; Nina N Nupponen; Lauri A Aaltonen; Hartmut P H Neumann; Charis Eng
Journal:  Am J Hum Genet       Date:  2003-12-18       Impact factor: 11.025

7.  The R22X mutation of the SDHD gene in hereditary paraganglioma abolishes the enzymatic activity of complex II in the mitochondrial respiratory chain and activates the hypoxia pathway.

Authors:  A P Gimenez-Roqueplo; J Favier; P Rustin; J J Mourad; P F Plouin; P Corvol; A Rötig; X Jeunemaitre
Journal:  Am J Hum Genet       Date:  2001-10-16       Impact factor: 11.025

Review 8.  Carney triad: a syndrome featuring paraganglionic, adrenocortical, and possibly other endocrine tumors.

Authors:  J Aidan Carney
Journal:  J Clin Endocrinol Metab       Date:  2009-09-01       Impact factor: 5.958

Review 9.  The triad of paragangliomas, gastric stromal tumours and pulmonary chondromas (Carney triad), and the dyad of paragangliomas and gastric stromal sarcomas (Carney-Stratakis syndrome): molecular genetics and clinical implications.

Authors:  C A Stratakis; J A Carney
Journal:  J Intern Med       Date:  2009-07       Impact factor: 8.989

10.  A HIF1alpha regulatory loop links hypoxia and mitochondrial signals in pheochromocytomas.

Authors:  Patricia L M Dahia; Ken N Ross; Matthew E Wright; César Y Hayashida; Sandro Santagata; Marta Barontini; Andrew L Kung; Gabriela Sanso; James F Powers; Arthur S Tischler; Richard Hodin; Shannon Heitritter; Francis Moore; Robert Dluhy; Julie Ann Sosa; I Tolgay Ocal; Diana E Benn; Deborah J Marsh; Bruce G Robinson; Katherine Schneider; Judy Garber; Seth M Arum; Márta Korbonits; Ashley Grossman; Pascal Pigny; Sérgio P A Toledo; Vania Nosé; Cheng Li; Charles D Stiles
Journal:  PLoS Genet       Date:  2005-07-25       Impact factor: 5.917

View more
  103 in total

1.  Carney Stratakis syndrome in a patient with SDHD mutation.

Authors:  Carmen Tenorio Jiménez; Louise Izatt; Fuju Chang; Mufaddal T Moonim; Paul V Carroll; Barbara M McGowan
Journal:  Endocr Pathol       Date:  2012-09       Impact factor: 3.943

2.  Pharmacological Inhibition of KIT Activates MET Signaling in Gastrointestinal Stromal Tumors.

Authors:  Noah A Cohen; Shan Zeng; Adrian M Seifert; Teresa S Kim; Eric C Sorenson; Jonathan B Greer; Michael J Beckman; Juan A Santamaria-Barria; Megan H Crawley; Benjamin L Green; Ferdinand Rossi; Peter Besmer; Cristina R Antonescu; Ronald P DeMatteo
Journal:  Cancer Res       Date:  2015-04-02       Impact factor: 12.701

Review 3.  Tailored management of primary gastrointestinal stromal tumors.

Authors:  Mark S Etherington; Ronald P DeMatteo
Journal:  Cancer       Date:  2019-04-01       Impact factor: 6.860

Review 4.  GISTogram: a graphic presentation of the growing GIST complexity.

Authors:  Riccardo Ricci; Angelo Paolo Dei Tos; Guido Rindi
Journal:  Virchows Arch       Date:  2013-08-23       Impact factor: 4.064

5.  Predictors of lymph node metastasis in patients with gastrointestinal stromal tumors (GISTs).

Authors:  Apostolos Gaitanidis; Mustapha El Lakis; Michail Alevizakos; Alexandra Tsaroucha; Michail Pitiakoudis
Journal:  Langenbecks Arch Surg       Date:  2018-05-31       Impact factor: 3.445

Review 6.  The genetic landscape of gastrointestinal stromal tumor lacking KIT and PDGFRA mutations.

Authors:  Sosipatros A Boikos; Constantine A Stratakis
Journal:  Endocrine       Date:  2014-07-16       Impact factor: 3.633

Review 7.  What is New in Gastrointestinal Stromal Tumor?

Authors:  Inga-Marie Schaefer; Adrián Mariño-Enríquez; Jonathan A Fletcher
Journal:  Adv Anat Pathol       Date:  2017-09       Impact factor: 3.875

Review 8.  Gastrointestinal stromal tumors: management of metastatic disease and emerging therapies.

Authors:  Joseph Vadakara; Margaret von Mehren
Journal:  Hematol Oncol Clin North Am       Date:  2013-10       Impact factor: 3.722

9.  Mapping of succinate dehydrogenase losses in 2258 epithelial neoplasms.

Authors:  Markku Miettinen; Maarit Sarlomo-Rikala; Peter McCue; Piotr Czapiewski; Renata Langfort; Piotr Waloszczyk; Krzysztof Wazny; Wojciech Biernat; Jerzy Lasota; Zengfeng Wang
Journal:  Appl Immunohistochem Mol Morphol       Date:  2014-01

10.  Analysis of all subunits, SDHA, SDHB, SDHC, SDHD, of the succinate dehydrogenase complex in KIT/PDGFRA wild-type GIST.

Authors:  Maria A Pantaleo; Annalisa Astolfi; Milena Urbini; Margherita Nannini; Paola Paterini; Valentina Indio; Maristella Saponara; Serena Formica; Claudio Ceccarelli; Rita Casadio; Giulio Rossi; Federica Bertolini; Donatella Santini; Maria G Pirini; Michelangelo Fiorentino; Umberto Basso; Guido Biasco
Journal:  Eur J Hum Genet       Date:  2013-04-24       Impact factor: 4.246

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.